Results with Lifescozul

Juliana Baquero - Colon Cancer- Resultados con LifEscozul™ Colon Cancer

Introduction to the case

For those who follow us and also follow the evolution of our patients, they will notice a continuous pattern in our cases: most of them arrive at an advanced or very advanced stage within the disease itself.

The case presented today by the LifEscozul Group (escozul, blue scorpion venom, blue scorpion) is no exception.

The patient's condition before starting with LifEscozul, the most effective and safest formulation made with blue scorpion venom, was really complicated, to the point that in the medical evaluation carried out between the Medical Committee and the Head of Clinical Trials, it was decided not to accept the case under the criterion that there would not be time to generate effect.

However, the case was accepted, it was proposed to start with very concentrated doses and observing its evolution very well.

After one year of treatment, these are the results.

  • Clinical Data

    Juliana Andrea Baquero Sánchez, 38 years old at the beginning of treatment with LifEscozul.

  • Symptomatology

    Anorexia, insomnia, pain, incapacitated.

  • Protocol Start

    May 16, 2019

  • Diagnostics

    Well-differentiated, infiltrating adenocarcinoma of the colon, treated with chemotherapy, radiotherapy and subsequent surgery and neoadjuvant chemotherapy. Post chemotherapy examinations revealed pulmonary and hepatic metastasis.

Background

In June 2017 Juliana was diagnosed through colonoscopy with colon cancer. She received chemotherapies and radiotherapies, and in December 2017 they removed the tumor which spanned approximately 10cm.

Postoperatively she received 8 more chemotherapies with the intention of removing any malignant cells or focus that had survived the operation.

This is standard procedure, however once the chemotherapy was completed, the doctors proceeded to perform follow-up examinations and discovered that Juliana now had tumor lesions in her liver and lung.

At this point Juliana's quality of life was very limited, affected by 2 years of treatments, going in and out of the hospital and all her indicators were affected.

By the time she arrived at LifEscozul Group in May 2019, she was no longer receiving other treatments and was sent home evicted.

At this point treatment with LifEscozul was her last hope.

Evolution with LifEscozul and actual results

One of the first things Juliana reported to us were the changes in her condition. She started getting out of bed, eating and having more energy.

A fighter at last, Juliana has been the one keeping the medical team informed of her progress.

By July 2019, only two months into treatment with LifEscozul, Juliana sends us a PET-CT report showing a significant decrease in lung metastasis, which went from 9.8 mm to 4 mm. And as if this were not enough, the liver metastasis had disappeared.

At this point, this result was so impressive that it forced us to review the case completely as we had never before had such a great result in such a short time.

We decided to be cautious and maintain the criteria of the patient's critical condition and wait for a new report.

During this period we were perceiving in Juliana a noticeable change in her quality of life, in her well-being and in her recovery gradually.

In April 2020 the previous results were not only maintained but the lung metastasis decreased even more to 3.2 mm.

At this point, this result was so impressive that it forced us to review the case completely because we had never before had such a great result in such a short time.

We decided to be cautious and maintain the criteria of the patient's critical condition and wait for a new report.

During this period we were perceiving in Juliana a noticeable change in her quality of life, in her well-being and in her recovery gradually.

In April 2020 the previous results were not only maintained but the lung metastasis decreased even more to 3.2 mm.

At this point we must point out that from the beginning Juliana has not received any treatment other than LifEscozul.

At the present date and due to the pandemic we have not been able to request new tests to Juliana, however she remains without relapses and with excellent quality of life as you can see in the video that accompanies this article.

Resumen

When cancer strikes, it can do so with lightning speed, giving no time for anything. Its aggressiveness is one of the biggest headaches for the scientific community.

Juliana tried everything the doctors offered her: surgery, chemotherapy and radiotherapy. However, the cancer metastasized to her liver and lung and Juliana was sent home, hopeless.

She came to us as a last resort, and knowing that her margin of recovery was very small, we opted to start with a very high and very aggressive dose.

This approach was rewarded when after 2 months and impressively we learned, through medical tests, that the lung metastasis had been reduced by more than 50% and the liver metastasis had completely disappeared.

One year later, and only with LifEscozul, Juliana has recovered her quality of life to pre-disease level and her lung nodule continues to shrink.

It has been and is a great result, one that justifies that for each patient we must fight to the end.

We are the LifEscozul Group and Results Define Us.

Next case

Eberto Gómez - Prostate Cancer- Resultados con LifEscozul™

Eberto Gómez

Eberto was diagnosed with aggressive stage IV prostate cancer in June 2017. The prognosis for life unfortunately for this type of cancer and stage is not good. Mr. Eberto received hormone therapy treatment with Bicalutamide and Decapeptil as part of his conventional treatments. He also received, additionally radiotherapy on lumbar spine in July 2017. View more